drugset / Trial / NCT01044381

Open-Label Pharmacokinetics (PK)/Safety Study of Luliconazole Solution, 10% in Distal Subungual Onychomycosis

NCT01044381

Phase 1/2 Completed 24 enrolled Topica Pharmaceuticals
NaSingle-groupOpen-labelTreatment

Summary

To determine the safety, tolerability, systemic exposure and pharmacokinetics of luliconazole after repeat daily topical application of Luliconazole Solution, 10% in a maximal use setting in adults with distal subungual onychomycosis of the toenails.

Timeline

Start
2010-12
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Luliconazole Small molecule 10 % Topical

Indications